16.BPS8 Best practice statement
Suitability of the seating and wheelchair system should be evaluated on an…
Suitability of the seating and wheelchair system should be evaluated on an annual basis in adults and biannually in children.
Part of 16 Digital and assistive technologies in Friedreich ataxia
References (32)
1. Marsden J, Harris C. Cerebellar ataxia: pathophysiology and rehabilitation. Clin Rehabil. 2011;25(3):195-216.
2. Clark J, Shona M, Morrow M. Wheelchair postural support for young people with progressive neuromuscular disorders. International Journal of Therapy and Rehabiliation 2004;11(8):365-73.
3. Wendrich K, van Oirschot P, Martens MB, Heerings M, Jongen PJ, Krabbenborg L. Toward digital self-monitoring of multiple sclerosis: investigating first experiences, needs, and wishes of people with MS. Int J MS Care. 2019;21(6):282-91.
4. Londral A, Pinto A, Pinto S, Azevedo L, De Carvalho M. Quality of life in amyotrophic lateral sclerosis patients and caregivers: Impact of assistive communication from early stages. Muscle Nerve. 2015;52(6):933-41.
5. Broadhurst MJ, Stammers CW. Mechanical feeding aids for patients with ataxia: design considerations. J Biomed Eng. 1990;12(3):209-14.
6. Wyckoff E. The spoon phase is another option for self-feeding. Am J Occup Ther. 1993;47(9):851.
7. Morgan MH. Ataxia and weights. Physiotherapy. 1975;61(11):332-4.
8. Morrice BL, Becker WJ, Hoffer JA, Lee RG. Manual tracking performance in patients with cerebellar incoordination: effects of mechanical loading. Can J Neurol Sci. 1990;17(3):275-85.
9. Dahlin-Webb SR. A weighted wrist cuff. Am J Occup Ther. 1986;40(5):363-4.
10. Sanes JN, LeWitt PA, Mauritz KH. Visual and mechanical control of postural and kinetic tremor in cerebellar system disorders. J Neurol Neurosurg Psychiatry. 1988;51(7):934-43.
11. Bastian AJ. Mechanisms of ataxia. Phys Ther. 1997;77(6):672-5.
12. Gillen G. Improving activities of daily living performance in an adult with ataxia. Am J Occup Ther. 2000;54(1):89-96.
13. Davis AE, Lee RG. EMG biofeedback in patients with motor disorders: an aid for co-ordinating activity in antagonistic muscle groups. Can J Neurol Sci. 1980;7(3):199-206.
14. Guercio J, Chittum R, McMorrow M. Self-management in the treatment of ataxia: a case study in reducing ataxic tremor through relaxation and biofeedback. Brain Inj. 1997;11(5):353-62.
15. Guercio JM, Ferguson KE, McMorrow MJ. Increasing functional communication through relaxation training and neuromuscular feedback. Brain Inj. 2001;15(12):1073-82.
16. Mortenson WB, Miller WC, Miller-Pogar J. Measuring wheelchair intervention outcomes: Development of the wheelchair outcome measure. Disabil rehabilitation: Assist Technol. 2007;2(5):275-85.
17. Richardson M, Frank AO. Electric powered wheelchairs for those with muscular dystrophy: problems of posture, pain and deformity. Disabil Rehabil Assist Technol. 2009;4(3):181-8.
18. Cooper RA, Koontz AM, Ding D, Kelleher A, Rice I, Cooper R. Manual wheeled mobility--current and future developments from the human engineering research laboratories. Disabil Rehabil. 2010;32(26):2210-21.
19. Burgman I. The trunk/spine complex and wheelchair seating for children: A literature review Aust Occup Ther J. 1994;41(3):123-32.
20. Stockton L, Gebhardt KS, Clark M. Seating and pressure ulcers: clinical practice guideline. J Tissue Viability. 2009;18(4):98-108.
21. McCarthy RE. Management of neuromuscular scoliosis. Orthop Clin North Am. 1999;30(3):435-49.
22. Holmes KJ, Michael SM, Thorpe SL, Solomonidis SE. Management of scoliosis with special seating for the non-ambulant spastic cerebral palsy population – a biomechanical study. Clinical Biomechanics. 2003;18:480-7.
23. Ferrarin M, Andreoni G, Pedotti A. Comparative biomechanical evaluation of different wheelchair seat cushions. J Rehabil Res Dev. 2000;37(3):315-24.
24. De Souza LH, Frank AO. Rare diseases: matching wheelchair users with rare metabolic, neuromuscular or neurological disorders to electric powered indoor/outdoor wheelchairs (EPIOCs). Disabil Rehabil. 2016;38(16):1547-56.
25. Parent F, Dansereau J, Lacoste M, Aissaouri R. Evaluation of the new flexible contour backrest for wheelchairs J Rehabil Res Dev. 2000;37(3):325-33.
26. Liu HY, Pearlman J, Cooper R, Hong EK, Wang H, Salatin B, et al. Evaluation of aluminum ultralight rigid wheelchairs versus other ultralight wheelchairs using ANSI/RESNA standards. J Rehabil Res Dev. 2010;47(5):441-55.
27. Freixes O, Fernandez SA, Gatti MA, Crespo MJ, Olmos LE, Rubel IF. Wheelchair axle position effect on start-up propulsion performance of persons with tetraplegia. J Rehabil Res Dev. 2010;47(7):661-8.
28. Salminen AL, Brandt A, Samuelsson K, Toytari O, Malmivaara A. Mobility devices to promote activity and participation: a systematic review. J Rehabil Med. 2009;41(9):697-706.
29. Mountain AD, Kirby RL, Smith C. Skills training: an important component of powered wheelchair use. Clin Rehabil. 2009;23(3):287.
30. Mateo I, Llorca J, Volpini V, Corral J, Berciano J, Combarros O. Expanded GAA repeats and clinical variation in Friedreich's ataxia. Acta Neurol Scand. 2004;109(1):75-8.
31. La Pean A, Jeffries N, Grow C, Ravina B, Di Prospero NA. Predictors of progression in patients with Friedreich ataxia. Mov Disord. 2008;23(14):2026-32.
32. Delatycki MB, Paris DB, Gardner RJ, Nicholson GA, Nassif N, Storey E, et al. Clinical and genetic study of Friedreich ataxia in an Australian population. Am J Med Genet. 1999;87(2):168-74.
Disclaimer, intended use and funding
Disclaimer
The Clinical Management Guidelines for Friedreich ataxia (‘Guidelines’) are protected by copyright owned by the authors who contributed to their development or said authors’ assignees.
These Guidelines are systematically developed evidence statements incorporating data from a comprehensive literature review of the most recent studies available (up to the Guidelines submission date) and reviewed according to the Grading of Recommendations, Assessment Development and Evaluations (GRADE) framework © The Grade Working Group.
Guidelines users must seek out the most recent information that might supersede the diagnostic and treatment recommendations contained within these Guidelines and consider local variations in clinical settings, funding and resources that may impact on the implementation of the recommendations set out in these Guidelines.
The authors of these Guidelines disclaim all liability for the accuracy or completeness of the Guidelines, and disclaim all warranties, express or implied to their incorrect use.
Intended Use
These Guidelines are made available as general information only and do not constitute medical advice. These Guidelines are intended to assist qualified healthcare professionals make informed treatment decisions about the care of individuals with Friedreich ataxia. They are not intended as a sole source of guidance in managing issues related to Friedreich ataxia. Rather, they are designed to assist clinicians by providing an evidence-based framework for decision-making.
These Guidelines are not intended to replace clinical judgment and other approaches to diagnosing and managing problems associated with Friedreich ataxia which may be appropriate in specific circumstances. Ultimately, healthcare professionals must make their own treatment decisions on a case-by-case basis, after consultation with their patients, using their clinical judgment, knowledge and expertise.
Guidelines users must not edit or modify the Guidelines in any way – including removing any branding, acknowledgement, authorship or copyright notice.
Funding
The authors of this document gratefully acknowledge the support of the Friedreich Ataxia Research Alliance (FARA). The views and opinions expressed in the Guidelines are solely those of the authors and do not necessarily reflect the official policy or position of FARA.